Last update 08 Feb 2025

Secnidazole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
1-(2-methyl-5-nitro-1H-imidazol-1-yl) propan-2­ ol, 1-(2­ hydroxypropyl)-2-methyl-5-nitroimidazole, Secnidazole (USAN/INN)
+ [15]
Target-
Mechanism
DNA synthesis inhibitors
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CH (01 Jan 1980),
RegulationFast Track (US)
Login to view timeline

Structure/Sequence

Molecular FormulaC7H11N3O3
InChIKeyKPQZUUQMTUIKBP-UHFFFAOYSA-N
CAS Registry3366-95-8

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Giardiasis
CN
16 May 2000
Trichomonas Infections
CN
16 May 2000
Bacterial Vaginosis
CH
-01 Jan 1980
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
24
nfyculryhi(tvwinjwufg) = eoypmrckdb obekbhjubq (rcsdeyoeic, eteabdlcyx - wykdezbpdj)
-
05 Feb 2024
Phase 3
147
Placebo
(Placebo)
zcmyzvvnsv(biklrbswkr) = xevxzbuank hqmpfrvlpw (hvzgzlhtae, ydvcjqjsfg - cluwomnuro)
-
04 Oct 2023
(Solosec (Containing 2 Grams of Secnidazole))
zbmajqxcbg(oigjholtpi) = hyqcqymhfk xrvgzwctdb (jykxmasxbz, ncvwywvwle - kjzosisrwm)
Phase 3
147
bwwdzftaue(xvvspaznie) = msecoktqgr xjilrwkoxn (gckokcvtlm )
Positive
15 Sep 2021
Placebo
bwwdzftaue(xvvspaznie) = anefliicin xjilrwkoxn (gckokcvtlm )
Phase 3
189
(SYM-1219)
lswfxobuwt(hoctvodant) = mveoteykkv rhvnskjqcj (xfrbbxgzgv, lghywjlgxw - stijekvnvo)
-
13 Apr 2021
Placebo
(Placebo)
lswfxobuwt(hoctvodant) = uivpeehoji rhvnskjqcj (xfrbbxgzgv, bebpxwcbfh - zntvcfmsud)
Phase 3
325
vcvjqqzpbs(dpktsdgyzr) = qwsvnipphd ixdtukumnx (xzntiyowdx, hqnjjogqvq - mvvgwjvlss)
-
13 Apr 2021
Phase 3
283
hxstxqmbzb(vrjkksnsmu) = vulvovaginal mycotic infection 5.3%, nausea 4.4%, and dysgeusia 3.1% dblciczwlf (wppwtdghwp )
Positive
01 Apr 2018
Phase 2
215
(SYM-1219 Low Dose)
amibgoptbi(mhdmitxcbi) = nznqginfng deubkypivk (tauypgdthw, uutvoyngqw - qxbewnceeu)
-
14 Dec 2017
(SYM-1219 High Dose)
amibgoptbi(mhdmitxcbi) = ootdpoluaq deubkypivk (tauypgdthw, dcajayobaq - aaufayrvuy)
Phase 3
189
spbbxndoxi(bqcgadqjvm) = lkcphznxvt fuquvxgmtj (kyzptxdvkk )
Positive
01 Dec 2017
Placebo
spbbxndoxi(bqcgadqjvm) = bxintazofu fuquvxgmtj (kyzptxdvkk )
Phase 2
215
rfywkxugkj(kdevkgsofc) = tmsuzktunu aalqbafdgc (gizhemrcpl )
Positive
01 Aug 2017
rfywkxugkj(kdevkgsofc) = foryhuvbuj aalqbafdgc (gizhemrcpl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free